The Heightened Risk of Deep Venous Thrombosis and Pulmonary Embolism in Patients with Cutaneous Lupus Erythematosus

Authors

  • Christopher G. Gibson Department of Internal Medicine, Fairfield Medical Center, Lancaster, Ohio, USA
  • Bhakti B. Chavan Ohio University Heritage College of Osteopathic Medicine, Dublin, OH, USA
  • Ruby S. Gibson Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX, USA
  • Benjamin Strickland Kirksville College of Osteopathic Medicine, Kirksville, MO, USA
  • Adam D. Fratczak Ohio University Heritage College of Osteopathic Medicine, Dublin, OH, USA
  • Robert L. Zee Department of Internal Medicine, Fairfield Medical Center, Lancaster, Ohio, USA
  • Stephanie J. Ott Department of Rheumatology at the Fairfield Medical Center, Lancaster, OH, USA
  • Irving L. Rosenberg Department of Rheumatology at the Fairfield Medical Center, Lancaster, OH, USA

DOI:

https://doi.org/10.12970/2310-9874.2020.08.02

Keywords:

Cutaneous Lupus, Epidemiology, Inflammation, Deep Vein Thrombosis, Pulmonary Embolism.

Abstract

Background: Lupus is an inflammatory disorder that involves many different organ systems. One of these systems is coagulation cascade. This leads to increased rate of venous thromboembolism (VTE). Isolated cutaneous lupus (CLE) is typically thought to just be limited to cutaneous structures. However, there has been very little studies on evaluating the risk of VTE in patients with CLE. This paper attempts to outline whether CLE is a risk factor for VTE.

Methods: Two large databases of patient information were used, the NIS, and HCUP. Using the ICD 9-10 codes from these discharge summaries it was possible to see which patients had both an in-hospital diagnosis of VTE and CLE. Patients with other rheumatologic diseases aside from CLE were excluded.

Results: A total of 3551 patients with CLE and 35,608 with SLE were identified in the 2015-2016 population. CLE and SLE were associated with a statistically significant increased risk of VTE in adjusted and unadjusted analyses. 912 patients with SLE were diagnosed with VTE (2.6%) with a p-value of <0.001.

Conclusion: Through adjusted analysis of the discharge diagnosis it was found the 1.6% of patients also had an in hospital VTE diagnosis. This correlated with an increased risk of VTE with a p value of .0026.

References

https://news.uthsc.edu/announcements/uthsc-irb-policy-entitled-exemption-for-research-use-of-selected-de-identified-specimen-and-data-repositories/

Chabner D-E. The Language of Medicine. Elsevier Health Sciences 2013; p. 610. ISBN 978-1455728466.

Grönhagen CM, Nyberg F. Cutaneous lupus erythematosus: an update. Indian Dermatol Online J 2014; 5: 7-13. https://doi.org/10.4103/2229-5178.126020

Zoller B, Li X, Sundquist J, Sundquist K. Autoimmune diseases and venous thromboembolism: A review of the literature. Am J Cardiovasc Dis 2012; 2: 171-183.

Ahlehoff O, Wu JJ, Raunso J, et al. Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study. Lupus 2017; 26: 1435-9. https://doi.org/10.1177/0961203317716306

HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 2012. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/nisoverview.jsp

HCUP State Inpatient Databases (SID). Healthcare Cost and Utilization Project (HCUP). 2005-2009. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/sidoverview.jsp

Tektonidou MG, Wang Z, Dasgupta A, Ward MM. Burden of serious infections in adults with systemic lupus erythematosus: A national population-based study, 1996–2012. Arthritis Care Res 2015; 67: 1078-85. https://doi.org/10.1002/acr.22575

Jarrett P, Thornley S, Scragg R. Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand. Lupus 2016; 25(13): 1497-1502. https://doi.org/10.1177/0961203316651745

Gronhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol 2011; 164(6): 1335-1341. https://doi.org/10.1111/j.1365-2133.2011.10272.x

Deligny C, Clyti E, Sainte-Marie D, et al. Incidence of chronic cutaneous lupus erythematosus in French Guiana: a retrospective population-based study. Arthritis Care Res (Hoboken) 2010; 62(2): 279-282. https://doi.org/10.1002/acr.20079

Popovic K, Nyberg F, Wahren-Herlenius M, Nyberg F. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus. Arthritis Rheum 2007; 56(1): 255-264. https://doi.org/10.1002/art.22286

Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006; 15(5): 308-318. https://doi.org/10.1191/0961203306lu2305xx

Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol 2018; 30(2): 144-150. https://doi.org/10.1097/BOR.0000000000000480

Callen JP. Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic, and prognostic examination of 62 patients. Arch Dermatol 1982; 118(6): 412-416. https://doi.org/10.1001/archderm.118.6.412

Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979; 115(12): 1409-1415. https://doi.org/10.1001/archderm.1979.04010120007006

Deng JS, Sontheimer RD, Gilliam JN. Relationships between antinuclear and anti-Ro/SS-A antibodies in subacute cutaneous lupus erythematosus. J Am Acad Dermatol 1984; 11(3): 494-499. https://doi.org/10.1016/S0190-9622(84)70198-8

Tiao J, Feng R, Carr K, Okawa J, Werth VP. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE). J Am Acad Dermatol 2016; 74(5): 862-869. https://doi.org/10.1016/j.jaad.2015.12.029

Baltaci M, Fritsch P. Histologic features of cutaneous lupus erythematosus. Autoimmun Rev 2009; 8(6): 467-473. https://doi.org/10.1016/j.autrev.2008.12.014

Pascual V, Farkas L, Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol 2006; 18(6): 676-682. https://doi.org/10.1016/j.coi.2006.09.014

Downloads

Published

2020-04-20

Issue

Vol. 8 (2020)

Section

Articles